Biotech Startups

Novir develops point-of-care diagnostic tests and preventive healthcare solutions, initially focused on COVID-19 screening but expanded to include lead testing, vaccination services, biometrics, population health analytics, and drug testing. The company serves healthcare providers and organizations seeking rapid, reliable testing capabilities with immediate results.

1 investor

Novobiom develops fungi-based biotechnology solutions for soil remediation, waste management, and sustainable production. The company uses mycoremediation and biomimicry to address environmental challenges such as soil contamination, plastic breakdown, and textile waste recycling.

1 investor

NovoClade develops biological technologies, using organismal biology and computational design, to control invasive species that threaten agriculture, livestock, and ecosystems. Its platform selects GM or non-GM intervention formats based on the target species and deployment context, serving agricultural, animal agriculture, and ecological pest-control applications.

1 investor

NovoDaily is an Austrian biotech company that offers genetic testing, personalized supplements, and cosmetics along with lifestyle and nutrition recommendations based on an individual's genes, lifestyle, and goals. Its products are distributed through a network of official partners such as pharmacies, gyms, nutritionists, and health practitioners across Europe.

1 investor

NovoMedic combines DNA analyses (micronutrient, fitness, pharmacogenetic, and prevention genetics) with personalized micronutrient formulations, offered to patients exclusively under physician supervision. The company, part of DARWIN AG, also provides a health portal for doctors and a multi-cancer early-detection screening, with products made in Salzburg, Austria.

1 investor

Novomer (part of Danimer Scientific) develops biodegradable and compostable materials used in everyday products such as packaging and straws. The company focuses on sustainable materials for consumer and industrial applications, holding 480+ patents across two decades of research.

1 investor

Novonesis develops biological solutions for agriculture, animal feed, food production, and consumer products, helping customers improve crop yields, product quality, and sustainability. The company applies microbial and enzyme-based technologies to address food system challenges and reduce environmental impact across multiple industries.

1 investor

NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries. The device has received FDA Breakthrough Device Designation and supports the growth of new meniscus-like tissue as it resorbs.

1 investor

Novo Protein supplies GMP-grade mRNA enzymes, reagents, and diagnostic materials for biopharmaceutical research and production, including reagents for in vitro transcription, molecular diagnostics, gene editing, and immunoassay development.

1 investor

NovoPyxis applies mathematics and physics principles, including knot theory and fluid dynamics, to drug design and delivery, predicting protein structures of uncrystallized targets and designing peptide agonists. Its work includes a cardiomyopathy drug candidate and a transdermal device for delivering large-molecule drugs into skin.

1 investor

Eledon develops tegoprubart, an anti-CD40L antibody immunosuppressant for organ transplant recipients, aimed at preventing transplant rejection and extending organ longevity. The company is conducting clinical trials in kidney transplantation with expansion into liver transplants and xenotransplantation.

1 investor

NOVUSON develops biomedical instrumentation and medical devices, serving healthcare organizations and clinical environments. The company focuses on innovative medical technology across biomechanics, tissue engineering, and surgical device platforms.

1 investor

NovusTX Devices develops therapeutic ultrasound technology for clinical medical applications, particularly focusing on minimally invasive brain therapies using HIFU (high-intensity focused ultrasound). The company emerged from research collaboration at the Thunder Bay Regional Health Research Institute and the University of Calgary.

1 investor

Noxilizer develops a low-temperature, low-pressure nitrogen dioxide (NO₂) sterilization technology used to sterilize prefilled syringes, biologic drug-device combination products, and other sensitive medical products as an alternative to ethylene oxide. It serves pharmaceutical companies, biotech firms, and medical device manufacturers through lab services, R&D studies, regulatory support, IP licensing, and planned contract sterilization.

1 investor

nPhyla is a biotechnology company that uses environmental DNA (eDNA) and analytics to provide site-level biodiversity assessments, microbial screening, and reporting tools for mining companies. It serves mining operators, researchers, and regulators to support ecosystem monitoring, reclamation, and sustainability requirements, with samples drawn from mine sites across North America.

1 investor

NRGene leverages genomic data and AI to optimize crop development and breeding for sustainable agriculture. The company serves seed companies, agricultural producers, and agronomic organizations seeking to improve food security through data-driven plant genetics.

1 investor

NRx Pharmaceuticals develops medicines for people with unmet medical needs, focused on making untreatable diseases treatable. It operates in the pharmaceutical and biotech industry.

1 investor

Nordic Science Investments is an early-stage venture capital fund that invests in science-based startups and university spinouts across the Nordic region, with a focus on deeptech, health tech, and life sciences. The fund works with leading regional universities to commercialize frontier research and tackle global challenges.

1 investor

Nu-Tek BioSciences manufactures plant- and yeast-based cell culture nutrients and fermentation supplements for pharmaceutical and biotechnology companies. The company supplies ingredients for mammalian cell culture, industrial fermentation, and clinical nutrition applications.

1 investor

NUCAPS is a biotech company that develops and produces protein nano- and microencapsulated bioactives and probiotics as functional ingredients for food, supplements, and pharmaceuticals. Its PowerCaps3 technology improves the stability, absorption, and flavour of nutritional ingredients to support human health and nutrition.

1 investor

NucleoTech engineers BrainPortal carrier proteins that attach to therapeutic antibodies and oligonucleotides and transport them across the blood-brain barrier non-invasively, using a direct in vivo screening platform to test many candidates simultaneously. It advances internal CNS therapeutics and licenses its carriers to pharma and biotech partners.

1 investor

Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year. It operates sites including a Minnesota location and Springhouse Innovation Park in Pennsylvania.

1 investor

Nucliq Biologics analyzes the gut microbiome using AI, machine learning, and multi-omics science (metagenomics, transcriptomics, metabolomics) to identify microbial signatures and develop precision therapeutics. The company targets chronic, multifactorial diseases through therapies that modulate neuroimmune, gut-brain, and gut-skin axes.

1 investor

Develops small-molecule therapies targeting the nuclear envelope to treat chronic age-related diseases such as metabolic disorders, neurodegeneration, and cancer.

1 investor